← Leaderboards
Ajay Gopal
Fred Hutchinson Cancer Center
$4,782,402
Attributed
$4,782,402
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $443.6K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,782,402 · 7
By mechanism
P01$1,847,910 · 2
K24$865,680 · 1
P30$848,627 · 2
K23$653,890 · 1
R21$566,295 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Damian J. Green$13,222,447
- Hans-Peter Kiem$98,160,227
- Roland Bruno Walter$12,142,218
- Frederick R Appelbaum$23,398,619
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseToxic EffectLymphomaBaseB-LymphocytesTumorProtocols DocumentationSiteRadioimmunotherapyDisease-Free SurvivalRefractoryRelapseTransplantationOrganAutologous Stem Cell TransplantationRadiationLeukemia/LymphomaClinical ResearchEnsureSuccessMs4a1 GeneRituximabPre-ClinicalInnovation
Grant awards (29)
Protocol Review and Monitoring System$161,853
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$134,643
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$134,644
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$134,644
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$125,550
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$157,293
P30 · FY2020 · CA · contact PI
Molecularly Targeted Therapy for Lymphoma$171,401
K24 · FY2018 · CA · contact PI
Molecularly Targeted Therapy for Lymphoma$172,224
K24 · FY2017 · CA · contact PI
Molecularly Targeted Therapy for Lymphoma$173,074
K24 · FY2016 · CA · contact PI
Radioimmunotherapy for Lymphoma$269,552
P01 · FY2015 · CA · contact PI
Molecularly Targeted Therapy for Lymphoma$174,048
K24 · FY2015 · CA · contact PI
Radioimmunotherapy for Lymphoma$258,380
P01 · FY2014 · CA · contact PI
Molecularly Targeted Therapy for Lymphoma$174,933
K24 · FY2014 · CA · contact PI
Radioimmunotherapy for Lymphoma$256,316
P01 · FY2013 · CA · contact PI
Radioimmunotherapy for Lymphoma$274,285
P01 · FY2012 · CA · contact PI
Radioimmunotherapy for Lymphoma$275,955
P01 · FY2011 · CA · contact PI
Radiolabeled Antibody Therapy of B-Cell Lymphoma$95,473
P01 · FY2009 · CA · contact PI
Radiolabeled Antibody Therapy of B-Cell Lymphoma$92,832
P01 · FY2008 · CA · contact PI
Proapoptotic Therapy for B-cell Non Hodgkin's Lymphoma$272,362
R21 · FY2007 · CA · contact PI
Radiolabeled Antibody Therapy of B-Cell Lymphoma$92,292
P01 · FY2007 · CA · contact PI
Proapoptotic Therapy for B-cell Non Hodgkin's Lymphoma$293,933
R21 · FY2006 · CA · contact PI
Radiolabeled Antibody Therapy of B-Cell Lymphoma$48,170
P01 · FY2006 · CA · contact PI
Radiolabeled Antibody Therapy of B-Cell Lymphoma$184,655
P01 · FY2005 · CA
OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA$65,389
K23 · FY2005 · CA
OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA$130,778
K23 · FY2004 · CA
OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA$130,778
K23 · FY2003 · CA
OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA$65,389
K23 · FY2002 · CA
OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA$130,778
K23 · FY2001 · CA
OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA$130,778
K23 · FY2000 · CA